Aspirin, NOACs, Warfarin: which is the best choice to tackle cognitive decline in elderly patients? Insights from the GIRAF and ASCEND-Dementia trials presented at the AHA 2021.

Published in: European heart journal. Cardiovascular pharmacotherapy (2021)

Keyphrases